Chugai Pharmaceutical Co Stock Market Value
| CHGCF Stock | USD 46.34 5.27 12.83% |
| Symbol | Chugai |
Chugai Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Chugai Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Chugai Pharmaceutical.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Chugai Pharmaceutical on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Chugai Pharmaceutical Co or generate 0.0% return on investment in Chugai Pharmaceutical over 30 days. Chugai Pharmaceutical is related to or competes with Sanofi ADR, Bristol Myers, AstraZeneca PLC, Gilead Sciences, and Novartis. Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sa... More
Chugai Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Chugai Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Chugai Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.21 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 36.2 | |||
| Value At Risk | (9.20) | |||
| Potential Upside | 7.21 |
Chugai Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chugai Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Chugai Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Chugai Pharmaceutical historical prices to predict the future Chugai Pharmaceutical's volatility.| Risk Adjusted Performance | 0.0271 | |||
| Jensen Alpha | 0.0777 | |||
| Total Risk Alpha | (0.69) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.4757 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Chugai Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Chugai Pharmaceutical Backtested Returns
Chugai Pharmaceutical secures Sharpe Ratio (or Efficiency) of -0.0041, which signifies that the company had a -0.0041% return per unit of risk over the last 3 months. Chugai Pharmaceutical Co exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Chugai Pharmaceutical's Mean Deviation of 2.47, risk adjusted performance of 0.0271, and Downside Deviation of 6.21 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.22, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Chugai Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Chugai Pharmaceutical is expected to be smaller as well. At this point, Chugai Pharmaceutical has a negative expected return of -0.0191%. Please make sure to confirm Chugai Pharmaceutical's expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to decide if Chugai Pharmaceutical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.33 |
Below average predictability
Chugai Pharmaceutical Co has below average predictability. Overlapping area represents the amount of predictability between Chugai Pharmaceutical time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Chugai Pharmaceutical price movement. The serial correlation of 0.33 indicates that nearly 33.0% of current Chugai Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.33 | |
| Spearman Rank Test | 0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 11.41 |
Chugai Pharmaceutical lagged returns against current returns
Autocorrelation, which is Chugai Pharmaceutical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Chugai Pharmaceutical's pink sheet expected returns. We can calculate the autocorrelation of Chugai Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Chugai Pharmaceutical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Chugai Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Chugai Pharmaceutical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Chugai Pharmaceutical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Chugai Pharmaceutical pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Chugai Pharmaceutical Lagged Returns
When evaluating Chugai Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Chugai Pharmaceutical pink sheet have on its future price. Chugai Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Chugai Pharmaceutical autocorrelation shows the relationship between Chugai Pharmaceutical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Chugai Pharmaceutical Co.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Chugai Pink Sheet
Chugai Pharmaceutical financial ratios help investors to determine whether Chugai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chugai with respect to the benefits of owning Chugai Pharmaceutical security.